Selenofuranoside ameliorates memory loss in Alzheimer-like sporadic dementia: AChE activity, oxidative stress, and inflammation involvement

Oxidative Medicine and Cellular Longevity

Volumn 2015, Issue , 2015, Pages

  Chiapinotto Spiazzi, Cristiano ^a   Bucco Soares, Melina ^a   Pinto Izaguirry, Aryele ^a   Musacchio Vargas, Laura ^a   Zanchi, Mariane Magalhães ^a   Frasson Pavin, Natasha ^a   Ferreira Affeldt, Ricardo ^b   Seibert Lüdtke, Diogo ^b   Prigol, Marina ^a   Santos, Francielli Weber ^a  

^a UNIVERSIDADE FEDERAL DO PAMPA   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN; MAMMALS;

ALZHEIMER'S DISEASE; ANTIOXIDANT DEFENSE; DISTILLED WATER; INFLAMMATORY CYTOKINES; LIFE EXPECTANCIES; MORRIS WATER MAZE; PASSIVE AVOIDANCES; REACTIVE SPECIES;

NEURODEGENERATIVE DISEASES;

AMYLOID BETA PROTEIN[25-35]; GLUTATHIONE; INTERLEUKIN 6; ORGANOSELENIUM DERIVATIVE; REACTIVE OXYGEN METABOLITE; SELENOFURANOSIDE; UNCLASSIFIED DRUG; ACETYLCHOLINESTERASE; AMYLOID BETA PROTEIN; AMYLOID BETA-PROTEIN (25-35); CYTOKINE; GLUTATHIONE REDUCTASE; NEUROPROTECTIVE AGENT; PENTOSE; PEPTIDE FRAGMENT; SELENO-FURANOSIDE; SUPEROXIDE DISMUTASE;

ADULT; ALZHEIMER DISEASE; ALZHEIMER LIKE SPORADIC DEMENTIA; AMNESIA; ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; COGNITION; CONTROLLED STUDY; DEMENTIA; ENZYME ACTIVITY; INFLAMMATION; LOCOMOTION; MALE; MORRIS WATER MAZE TEST; MOUSE; NONHUMAN; OPEN FIELD TEST; OXIDATIVE STRESS; SINGLE DRUG DOSE; STEP-DOWN PASSIVE AVOIDANCE TEST; ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; COMPLICATION; DISEASE MODEL; DRUG EFFECTS; MAZE TEST; MEMORY DISORDERS; METABOLISM; PATHOLOGY;

ANIMALIA; BRASSICA NAPUS VAR. NAPUS; MUS;

ACETYLCHOLINESTERASE; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; CYTOKINES; DISEASE MODELS, ANIMAL; GLUTATHIONE; GLUTATHIONE REDUCTASE; INFLAMMATION; MALE; MAZE LEARNING; MEMORY DISORDERS; MICE; MOLECULAR STRUCTURE; NEUROPROTECTIVE AGENTS; ORGANOSELENIUM COMPOUNDS; OXIDATIVE STRESS; PENTOSES; PEPTIDE FRAGMENTS; REACTIVE OXYGEN SPECIES; SUPEROXIDE DISMUTASE;

EID: 84930958568     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2015/976908     Document Type: Article

References (35)

1. K. Blennow, M. J. de Leon, and H. Zetterberg, "Alzheimers disease, " The Lancet, vol. 368, no. 9533, pp. 387-403, 2006.
2. D. J. Selkoe, "Amyloid beta-protein and the genetics of Alzheimers disease, " The Journal of Biological Chemistry, vol. 271, no. 31, pp. 18295-18298, 1996.
3. M. E. Clementi, S. Marini, M. Coletta, F. Orsini, B. Giardina, and F. Misiti, "Abeta(31-35) and Abeta(25-35) fragments of amyloid beta-protein induce cellular death through apoptotic signals: role of the redox state of methionine-35, " FEBS Letters, vol. 579, no. 13, pp. 2913-2918, 2005.
4. S. T. Ferreira, J. R. Clarke, T. R. Bomfim, and F. G. de Felice, "Inflammation, defective insulin signaling, and neuronal dysfunction in Alzheimers disease, " Alzheimers and Dementia, vol. 10, no. 1, pp. S76-S83, 2014.
5. L. M. Vargas, M. B. Soares, A. P. Izaguirry et al., "Cadmium inhibits the ovary δ-aminolevulinate dehydratase activity in vitro and ex vivo: protective role of seleno-furanoside, " Journal of Applied Toxicology, vol. 33, no. 7, pp. 679-684, 2013.
6. S. G. N. Wollenhaupt, A. T. Soares, W. G. Salgueiro et al., "Seleno-and telluro-xylofuranosides attenuate Mn-induced toxicity in C. elegans via the DAF-16/FOXO pathway, " Food and Chemical Toxicology, vol. 64, pp. 192-199, 2014.
7. S. Pinton, A. C. Souza, M. H. M. Sari, R. M. Ramalho, C. M. P. Rodriguesb, and C. W. Nogueiraa, "P, p'-Methoxyl-diphenyl diselenide protects against amyloid-β induced cytotoxicity in vitro and improves memory deficits in vivo, " Behavioural Brain Research, vol. 247, pp. 241-247, 2013.
8. S. Pinton, T. B. Sampaio, R. M. Ramalho, C. M. P. Rodrigues, and C. W. Nogueira, "p, p'-Methoxyl-diphenyl diselenide prevents neurodegeneration and glial cell activation induced by streptozotocin in rats, " Journal of Alzheimers Disease, vol. 33, no. 1, pp. 133-144, 2013.
9. H. C. Braga, H. A. Stefani, M. W. Paixao, F. W. Santos, and D. S. Ludtke, "Synthesis of 5′-seleno-xylofuranosides, " Tetrahedron, vol. 66, no. 19, pp. 3441-3446, 2010.
10. H. H. Wang, C. J. Chou, J. F. Liao, and C. F. Chen, "Dehydroevodiamine attenuates β-amyloid peptide-induced amnesia in mice, " European Journal of Pharmacology, vol. 413, no. 2-3, pp. 221-225, 2001.
11. T. J. Haley and W. G. McCormick, "Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse, " British Journal of Pharmacology and Chemoterapy, vol. 12, no. 1, pp. 12-15, 1957.
12. R. Morris, "Developments of a water-maze procedure for studying spatial-learning in the rat, " Journal of Neuroscience Methods, vol. 11, no. 1, pp. 47-60, 1984.
13. M. Sakaguchi, M. Koseki, M. Wakamatsu, and E. Matsumura, "Effects of systemic administration of beta-casomorphin-5 on learning and memory in mice, " European Journal of Pharmacology, vol. 530, no. 1-2, pp. 81-87, 2006.
14. R. N. Walsh and R. A. Cummins, "The open-field test: a critical review, " Psychological Bulletin, vol. 83, no. 3, pp. 482-504, 1976.
15. H. P. Misra and I. Fridovich, "Therole of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase, " The Journal of Biological Chemistry, vol. 247, no. 10, pp. 3170-3175, 1972.
16. H. Aebi, "Catalase in vitro, "Methods in Enzymology, vol. 105, pp. 121-126, 1984.
17. D. E. Paglia and W. N. Valentine, "Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase, " The Journal of Laboratory and Clinical Medicine, vol. 70, no. 1, pp. 158-169, 1967.
18. W. H. Habig, M. J. Pabst, and W. B. Jakoby, "Glutathione S transferases. The first enzymatic step in mercapturic acid formation, " Journal of Biological Chemistry, vol. 249, no. 22, pp. 7130-7139, 1974.
19. I. Carlberg and B. Mannervik, "Glutathione reductase, " Methods in Enzymology, vol. 113, pp. 484-490, 1985.
20. P. J. Hissin and R. Hilf, "A fluorometric method for determination of oxidized and reduced glutathione in tissues, " Analytical Biochemistry, vol. 74, no. 1, pp. 214-226, 1976.
21. Q. Chen, E. J. Vazquez, S. Moghaddas, C. L. Hoppel, and E. J. Lesnefsky, "Production of reactive oxygen species by mitochondria-central role of complex III, " The Journal of Biological Chemistry, vol. 278, no. 38, pp. 36027-36031, 2003.
22. G. L. Ellman, K. D. Courtney, V. Andres Jr., and R. M. Featherstone, "A new and rapid colorimetric determination of acetylcholinesterase activity, " Biochemical Pharmacology, vol. 7, no. 2, pp. 88-90, 1961.
23. M. M. Bradford, "A rapid and sensitive method for the quantitation ofmicrogram quantities of protein utilizing the principle of protein dye binding, " Analytical Biochemistry, vol. 72, no. 1-2, pp. 248-254, 1976.
24. A. Diaz, K. Rojas, B. Espinosa et al., "Aminoguanidine treatment ameliorates inflammatory responses and memory impairment induced by amyloid-beta 25-35 injection in rats, " Neuropeptides, vol. 48, no. 3, pp. 153-159, 2014.
25. X. Wang, W. Wang, L. Li, G. Perry, H. G. Lee, and X. Zhu, "Oxidative stress andmitochondrial dysfunction in Alzheimers disease, " Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease, vol. 1842, no. 8, pp. 1240-1247, 2014.
26. A. M. Swomley, S. Forster, J. T. Keeney et al., "Abeta, oxidative stress in Alzheimer disease: evidence based on proteomics studies, " Biochimica et Biophysica Acta-Molecular Basis of Disease, vol. 1842, no. 8, pp. 1248-1257, 2014.
27. J. Kanski, M. Aksenova, C. Schoneich, and D. A. Butterfield, "Substitution of isoleucine-31 by helical-breaking proline abolishes oxidative stress and neurotoxic properties of Alzheimers amyloid β-peptide, " Free Radical Biology and Medicine, vol. 32, no. 11, pp. 1205-1211, 2002.
28. S. Varadarajan, J. Kanski, M. Aksenova, C. Lauderback, and D. A. Butterfield, "Different mechanisms of oxidative stress and neurotoxicity for Alzheimers Abeta(1-42) and Abeta(25-35), " Journal of the American Chemical Society, vol. 123, no. 24, pp. 5625-5631, 2001.
29. M. H. Yana, X. Wang, and X. Zhu, "Mitochondrial defects and oxidative stress in Alzheimer disease and Parkinson disease, " Free Radical Biology and Medicine, vol. 62, pp. 90-101, 2013.
30. W. Hassan, M. Ibrahim, and J. B. T. Rocha, "Towards the mechanism and comparative effect of diphenyl diselenide, diphenyl ditelluride and ebselen under various pathophysiological conditions in rats kidney preparation, " Chemico-Biological Interactions, vol. 182, no. 1, pp. 52-58, 2009.
31. S. Pinton, J. T. da Rocha, B. M. Gai, M. Prigol, L. V. da Rosa, and C. W. Nogueira, "Neuroprotector effect of p, p'-methoxyl-diphenyl diselenide in a model of sporadic dementia of Alzheimers type in mice: contribution of antioxidant mechanism, " Cell Biochemistry and Function, vol. 29, no. 3, pp. 235-243, 2011.
32. H. G. Kim, M. Moon, J. G. Choi et al., "Donepezil inhibits the amyloid-beta oligomer-induced microglial activation in vitro and in vivo, " NeuroToxicology, vol. 40, pp. 23-32, 2014.
33. K. Bhaskar, N. Maphis, G. Xu et al., "Microglial derived tumor necrosis factor-β drives Alzheimers disease-related neuronal cell cycle events, " Neurobiology of Disease, vol. 62, pp. 273-285, 2014.
34. D. Braida, P. Sacerdote, A. E. Panerai et al., "Cognitive function in young and adult IL (interleukin)-6 deficient mice, " Behavioural Brain Research, vol. 153, no. 2, pp. 423-429, 2004.
35. M. Singh, M. Kaur, H. Kukreja, R. Chugh, O. Silakari, and D. Singh, "Acetylcholinesterase inhibitors as Alzheimer therapy: from nerve toxins to neuroprotection, " European Journal of Medicinal Chemistry, vol. 70, pp. 165-188, 2013.